+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Bioinformatics Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083774
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bioinformatics Market grew from USD 13.33 billion in 2024 to USD 15.00 billion in 2025. It is expected to continue growing at a CAGR of 12.97%, reaching USD 27.72 billion by 2030.

The bioinformatics sector stands at a pivotal junction where data-driven insights are transforming life sciences, healthcare, and agricultural research. The convergence of high-throughput sequencing technologies, advanced computational tools, and expanding collaborative networks has generated an unprecedented volume of biological data. Consequently, organizations across academia, industry, and government are seeking robust solutions to manage, analyze, and derive actionable intelligence from these complex datasets. This executive summary delivers a concise yet comprehensive overview of the current dynamics reshaping the bioinformatics landscape in 2025. It addresses the implications of policy changes, technological breakthroughs, and evolving market structures, equipping stakeholders with the insights required to navigate emerging challenges and capitalize on growth opportunities. Through a structured analysis of transformative shifts, tariff impacts, segmentation, regional performance, and key industry players, this document lays the groundwork for informed decision-making. Ultimately, readers will gain a clear understanding of the strategic imperatives guiding investment, innovation, and collaboration in bioinformatics today.

Transformative Shifts Reshaping the Bioinformatics Landscape

Over the past two years, the bioinformatics domain has witnessed several transformative shifts that are redefining data analysis, service delivery, and platform development. First, the integration of artificial intelligence and machine learning into sequence analysis pipelines has accelerated variant interpretation and structural modeling, making predictive insights more accessible than ever before. Second, the rise of cloud-native bioinformatics platforms has enabled global collaboration, granting research teams instant access to scalable computational resources and real-time data sharing across geographic boundaries. Third, knowledge management tools have evolved to incorporate semantic data integration and intuitive visual analytics, streamlining the translation of raw data into research findings. Moreover, emerging trends in multi-omics integration are fostering holistic biological insights by correlating genomic, proteomic, and metabolomic information. These advancements are complemented by increased investment in cybersecurity protocols tailored to protect sensitive genetic data. Together, these shifts are not only enhancing analytical precision and throughput but also driving cost efficiencies. As a result, organizations are positioned to accelerate discovery cycles, reduce time to insight, and maintain competitive advantage in a rapidly evolving research environment.

Cumulative Impact of United States Tariffs in 2025

In 2025, United States tariff policies have introduced a cumulative impact that warrants close examination. The imposition of additional duties on imported sequencing instruments, reagents, and specialized computational hardware has led to price adjustments across the supply chain. Research laboratories and service providers have responded by renegotiating supplier contracts, seeking domestic alternatives, or postponing equipment upgrades. At the same time, downstream effects have materialized in the form of recalibrated project budgets and extended timelines for capacity expansion. On the other hand, certain vendors have localized production to mitigate tariff burdens, translating into reduced lead times and strengthened resilience against policy fluctuations. Additionally, partnerships between academic institutions and domestic manufacturers have gained traction, fostering innovation in reagent development and bespoke instrumentation. While short-term disruptions have challenged procurement processes, these adaptive strategies are setting a foundation for greater supply chain diversity and robustness. Consequently, stakeholders are encouraged to monitor ongoing regulatory developments and to adopt flexible sourcing models that can absorb potential future policy shifts without compromising research throughput or analytical integrity.

Key Segmentation Insights Across Products, Applications, and End Users

A nuanced understanding of market segmentation is essential for tailoring product offerings and service models. When dividing the market based on product types, the analysis encompasses bioinformatics platforms such as sequence alignment platforms, sequence analysis platforms, sequence manipulation platforms and structural & functional analysis platforms, bioinformatics services including data analysis, database management and sequencing, as well as knowledge management tools that support data curation and visualization. From an applications perspective, bioinformatics solutions are deployed across agricultural biotechnology where genetically modified organism development and plant breeding tools are paramount; clinical diagnostics benefiting from precision variant calling and diagnostic assay support; drug discovery & development featuring drug screening and target identification; genomics initiatives spanning comparative genomics and functional genomics; and proteomics & metabolomics workflows that decipher protein expression and metabolic pathways. End users range from academic & research institutes, comprising both research labs and universities, to agricultural & environmental sectors pursuing crop improvement and ecological monitoring, healthcare providers such as diagnostic centers and hospitals, and pharmaceutical & biotechnology companies driving therapeutic innovation. Each segment exhibits distinct requirements for data throughput, regulatory compliance, and integration capabilities. Consequently, vendors must align their roadmaps to address segment-specific pain points, thereby maximizing adoption and value creation.

Key Regional Insights Driving Strategic Growth

Regional performance varies significantly, offering strategic guidance on market entry and expansion. In the Americas, robust funding for genomics initiatives and a mature infrastructure for clinical diagnostics have fueled demand for advanced sequence analysis and multi-omics integration, reinforcing the region’s leadership in R&D intensity and commercial service offerings. Moving to Europe, Middle East & Africa, growth is driven by Pan-European collaborations on precision medicine and agricultural biotechnology projects that address food security, supported by regulatory frameworks that encourage cross-border data sharing. Meanwhile, in the Asia-Pacific region, emerging economies are investing heavily in local bioinformatics capabilities, with governments underwriting initiatives in genomic surveillance, personalized healthcare and biomanufacturing. Notably, strategic partnerships between multinational corporations and regional research institutes are accelerating technology transfer and capacity building. Each region’s unique funding models, regulatory landscapes and infrastructure maturity shape opportunity horizons. By aligning go-to-market strategies with these regional nuances, organizations can optimize resource allocation, forge high-impact collaborations and expedite time to value.

Key Companies Insights Highlighting Market Leadership and Innovation

The competitive environment is defined by a diverse set of leading players and innovative challengers. Notable contributors include 10x Genomics, Inc., which continues to pioneer single-cell sequencing technologies, and Agilent Technologies, Inc., recognized for its comprehensive analytical instrumentation. BGI Group remains a dominant force in large-scale sequencing services, while Bio-Rad Laboratories, Inc. offers a broad portfolio of genomics and proteomics platforms. BioDiscovery Group specializes in high-performance data interpretation software, and biomodal Limited advances machine learning-driven analytics. Dassault Systèmes S.E. provides integrated modeling solutions, and DNASTAR, Inc. is known for its intuitive sequence analysis suite. Eurofins Genomics LLC excels in outsourcing genomic assays. F. Hoffmann-La Roche Ltd leverages its diagnostics expertise to integrate bioinformatics into clinical workflows. Genevia Technologies Oy and Genomics Ltd. develop niche bioinformatics modules, while HaploX focuses on comparative genomics. Illumina, Inc. remains a cornerstone for sequencing platforms. Integrated DNA Technologies, Inc. supplies custom nucleic acid products, and Labcorp Genetics Inc. delivers decentralized genetic testing. Labvantage - Biomax GmbH integrates LIMS with bioinformatics, and Novo Nordisk A/S explores bioinformatics in drug development. Oxford Nanopore Technologies plc. drives portable sequencing, while Pacific Biosciences of California, Inc. advances long-read technologies. Partek Incorporated offers statistical genomics tools, and PerkinElmer, Inc. supports assay automation. Qiagen N.V. integrates sample-to-insight solutions, and RIKEN GENESIS CO.,LTD. contributes specialized sequencing services. SOPHiA GENETICS SA delivers AI-driven diagnostics, and Telesis Bio Inc. focuses on cloud-native platforms. Thermo Fisher Scientific Inc. provides end-to-end sequencing solutions, while Veracyte, Inc. applies genomics in thyroid and lung diagnostics. Waters Corporation enhances bioinformatics with advanced chromatography data analysis. This diverse ecosystem underscores the importance of continuous innovation and strategic partnerships for maintaining competitive advantage.

Actionable Recommendations for Industry Leaders

To navigate this dynamic environment, industry leaders should consider a suite of actionable strategies. First, invest in modular, interoperable platforms that facilitate seamless integration across sequence alignment, structural analysis and knowledge management modules, thereby reducing implementation complexity. Second, pursue strategic alliances with domestic component manufacturers to mitigate tariff volatility and accelerate localized production. Third, prioritize the development of AI-driven analytics capable of handling multi-omics datasets, which will differentiate offerings in a crowded market. Fourth, strengthen outreach to end-user segments by tailoring service packages for academic research labs, regulatory-compliant solutions for diagnostic centers and scalable pipelines for pharmaceutical R&D. Fifth, localize go-to-market approaches by establishing partnerships with regional research consortia in the Americas, Europe, Middle East & Africa, and Asia-Pacific, ensuring alignment with funding priorities and regulatory requirements. Sixth, enhance data security frameworks by adopting encryption, anonymization and blockchain-based audit trails to protect sensitive genomic information. Finally, cultivate talent by investing in training programs and collaborative research initiatives to build a skilled workforce capable of leveraging evolving bioinformatics tools and methodologies. By implementing these recommendations, organizations can increase resilience, drive differentiation and unlock new avenues of value.

Conclusion: Synthesizing Insights for Strategic Impact

In summary, the bioinformatics landscape in 2025 is characterized by rapid technological advancement, evolving policy environments and increasing segmentation by product, application and end user. The integration of AI and cloud-native solutions has streamlined research workflows, while tariff-driven supply chain adjustments have underscored the need for adaptive sourcing and localized partnerships. Regional disparities in funding, regulation and infrastructure present both challenges and opportunities for market expansion. Meanwhile, a broad array of companies continues to innovate across sequencing platforms, data analysis software and knowledge management systems. As stakeholders refine their strategic priorities, focusing on modular interoperability, AI-driven analytics, regional alignment and data security will be essential. Through these efforts, organizations can sustain growth, accelerate discovery and deliver impactful solutions that address global health, agricultural and environmental needs. The convergence of technological prowess, strategic agility and collaborative networks will define success in the years ahead, shaping a bioinformatics ecosystem that is more resilient, inclusive and discovery-driven.

Market Segmentation & Coverage

This research report categorizes the Bioinformatics Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Bioinformatics Platforms
    • Sequence Alignment Platforms
    • Sequence Analysis Platforms
    • Sequence Manipulation Platforms
    • Structural & Functional Analysis Platforms
  • Bioinformatics Services
    • Data Analysis
    • Database Management
    • Sequencing
  • Knowledge Management Tools
  • Agricultural Biotechnology
    • GMOs Development
    • Plant Breeding Tools
  • Clinical Diagnostics
  • Drug Discovery & Development
    • Drug Screening
    • Target Identification
  • Genomics
    • Comparative Genomics
    • Functional Genomics
  • Proteomics & Metabolomics
  • Academic & Research Institutes
    • Research Labs
    • Universities
  • Agricultural & Environmental Sectors
  • Healthcare Providers
    • Diagnostic Centers
    • Hospitals
  • Pharmaceutical & Biotechnology Companies

This research report categorizes the Bioinformatics Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bioinformatics Market to delves into recent significant developments and analyze trends in each of the following companies:

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDiscovery Group
  • biomodal Limited
  • Dassault Systèmes S.E.
  • DNASTAR, Inc.
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd
  • Genevia Technologies Oy
  • Genomics Ltd.
  • HaploX
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Labcorp Genetics Inc.
  • Labvantage - Biomax GmbH
  • Novo Nordisk A/S
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • RIKEN GENESIS CO.,LTD.
  • SOPHiA GENETICS SA
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
  • Waters Corporation

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioinformatics Market, by Product Types
8.1. Introduction
8.2. Bioinformatics Platforms
8.2.1. Sequence Alignment Platforms
8.2.2. Sequence Analysis Platforms
8.2.3. Sequence Manipulation Platforms
8.2.4. Structural & Functional Analysis Platforms
8.3. Bioinformatics Services
8.3.1. Data Analysis
8.3.2. Database Management
8.3.3. Sequencing
8.4. Knowledge Management Tools
9. Bioinformatics Market, by Applications
9.1. Introduction
9.2. Agricultural Biotechnology
9.2.1. GMOs Development
9.2.2. Plant Breeding Tools
9.3. Clinical Diagnostics
9.4. Drug Discovery & Development
9.4.1. Drug Screening
9.4.2. Target Identification
9.5. Genomics
9.5.1. Comparative Genomics
9.5.2. Functional Genomics
9.6. Proteomics & Metabolomics
10. Bioinformatics Market, by End-User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Research Labs
10.2.2. Universities
10.3. Agricultural & Environmental Sectors
10.4. Healthcare Providers
10.4.1. Diagnostic Centers
10.4.2. Hospitals
10.5. Pharmaceutical & Biotechnology Companies
11. Americas Bioinformatics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Bioinformatics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Bioinformatics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. 10x Genomics, Inc.
14.3.2. Agilent Technologies, Inc.
14.3.3. BGI Group
14.3.4. Bio-Rad Laboratories, Inc.
14.3.5. BioDiscovery Group
14.3.6. biomodal Limited
14.3.7. Dassault Systèmes S.E.
14.3.8. DNASTAR, Inc.
14.3.9. Eurofins Genomics LLC
14.3.10. F. Hoffmann-La Roche Ltd
14.3.11. Genevia Technologies Oy
14.3.12. Genomics Ltd.
14.3.13. HaploX
14.3.14. Illumina, Inc.
14.3.15. Integrated DNA Technologies, Inc.
14.3.16. Labcorp Genetics Inc.
14.3.17. Labvantage - Biomax GmbH
14.3.18. Novo Nordisk A/S
14.3.19. Oxford Nanopore Technologies plc.
14.3.20. Pacific Biosciences of California, Inc.
14.3.21. Partek Incorporated
14.3.22. PerkinElmer, Inc.
14.3.23. Qiagen N.V.
14.3.24. RIKEN GENESIS CO.,LTD.
14.3.25. SOPHiA GENETICS SA
14.3.26. Telesis Bio Inc.
14.3.27. Thermo Fisher Scientific Inc.
14.3.28. Veracyte, Inc.
14.3.29. Waters Corporation
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BIOINFORMATICS MARKET MULTI-CURRENCY
FIGURE 2. BIOINFORMATICS MARKET MULTI-LANGUAGE
FIGURE 3. BIOINFORMATICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIOINFORMATICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIOINFORMATICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOINFORMATICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOINFORMATICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOINFORMATICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE ALIGNMENT PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCE MANIPULATION PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOINFORMATICS MARKET SIZE, BY STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOINFORMATICS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOINFORMATICS MARKET SIZE, BY DATABASE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOINFORMATICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOINFORMATICS MARKET SIZE, BY KNOWLEDGE MANAGEMENT TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOINFORMATICS MARKET SIZE, BY GMOS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOINFORMATICS MARKET SIZE, BY PLANT BREEDING TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOINFORMATICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOINFORMATICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOINFORMATICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOINFORMATICS MARKET SIZE, BY COMPARATIVE GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOINFORMATICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOINFORMATICS MARKET SIZE, BY PROTEOMICS & METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOINFORMATICS MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOINFORMATICS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL & ENVIRONMENTAL SECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOINFORMATICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOINFORMATICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOINFORMATICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BIOINFORMATICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 125. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 128. CHINA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 129. CHINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 130. CHINA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 131. CHINA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 132. CHINA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. CHINA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 134. CHINA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 135. CHINA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. CHINA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 137. CHINA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 138. INDIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 139. INDIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 140. INDIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 141. INDIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 142. INDIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. INDIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 144. INDIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 145. INDIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. INDIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. INDIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 155. INDONESIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. INDONESIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 157. INDONESIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 158. JAPAN BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 159. JAPAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 160. JAPAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 161. JAPAN BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 162. JAPAN BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. JAPAN BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 164. JAPAN BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 165. JAPAN BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. JAPAN BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 167. JAPAN BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 175. MALAYSIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. MALAYSIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 185. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 187. PHILIPPINES BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 195. SINGAPORE BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. SINGAPORE BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 197. SINGAPORE BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 207. SOUTH KOREA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 215. TAIWAN BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. TAIWAN BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 217. TAIWAN BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 218. THAILAND BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 219. THAILAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 220. THAILAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 221. THAILAND BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 222. THAILAND BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. THAILAND BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 224. THAILAND BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 225. THAILAND BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. THAILAND BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 227. THAILAND BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 235. VIETNAM BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. VIETNAM BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 237. VIETNAM BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOINFORMATICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 249. DENMARK BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 257. DENMARK BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 258. DENMARK BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 259. EGYPT BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 260. EGYPT BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 261. EGYPT BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 262. EGYPT BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 263. EGYPT BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. EGYPT BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 265. EGYPT BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 266. EGYPT BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. EGYPT BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 268. EGYPT BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 269. FINLAND BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 270. FINLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 271. FINLAND BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 272. FINLAND BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 273. FINLAND BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. FINLAND BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 275. FINLAND BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 276. FINLAND BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. FINLAND BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 278. FINLAND BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 279. FRANCE BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 280. FRANCE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 281. FRANCE BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 282. FRANCE BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 283. FRANCE BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. FRANCE BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 285. FRANCE BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 286. FRANCE BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. FRANCE BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 288. FRANCE BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 289. GERMANY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 290. GERMANY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 291. GERMANY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 292. GERMANY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 293. GERMANY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. GERMANY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 295. GERMANY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 296. GERMANY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 297. GERMANY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 298. GERMANY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 306. ISRAEL BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 307. ISRAEL BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 308. ISRAEL BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 309. ITALY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 310. ITALY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 311. ITALY BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 312. ITALY BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 313. ITALY BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. ITALY BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 315. ITALY BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 316. ITALY BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 317. ITALY BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 318. ITALY BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 325. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 326. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 329. NIGERIA BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 330. NIGERIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS PLATFORMS, 2018-2030 (USD MILLION)
TABLE 331. NIGERIA BIOINFORMATICS MARKET SIZE, BY BIOINFORMATICS SERVICES, 2018-2030 (USD MILLION)
TABLE 332. NIGERIA BIOINFORMATICS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 333. NIGERIA BIOINFORMATICS MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 334. NIGERIA BIOINFORMATICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 335. NIGERIA BIOINFORMATICS MARKET SIZE, BY GENOMICS, 2018-2030 (USD MILLION)
TABLE 336. NIGERIA BIOINFORMATICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 337. NIGERIA BIOINFORMATICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 338. NIGERIA BIOINFORMATICS MARKET SIZE, BY HEALTHCARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 339. NORWAY BIOINFORMATICS MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TAB

Companies Mentioned

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • BioDiscovery Group
  • biomodal Limited
  • Dassault Systèmes S.E.
  • DNASTAR, Inc.
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche Ltd
  • Genevia Technologies Oy
  • Genomics Ltd.
  • HaploX
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Labcorp Genetics Inc.
  • Labvantage - Biomax GmbH
  • Novo Nordisk A/S
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • Partek Incorporated
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • RIKEN GENESIS CO.,LTD.
  • SOPHiA GENETICS SA
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
  • Waters Corporation

Methodology

Loading
LOADING...